Changes in equity
in € millions |
Subscribed share capital |
Additional paid-in capital |
Cashflow hedge reserve |
Cumulative translation reserves |
Other (legal) reserves and undistributed profit |
Shareholders’ equity |
Non-controlling interests |
Group equity |
Balance at December 31, 2017 |
505 |
769 |
15 |
(549) |
5,125 |
5,865 |
442 |
6,307 |
Impact adoption IFRS 9 |
– |
– |
– |
– |
(3) |
(3) |
– |
(3) |
Impact adoption IFRS 15 |
– |
– |
– |
– |
(43) |
(43) |
(5) |
(48) |
Balance at January 1, 2018 |
505 |
769 |
15 |
(549) |
5,079 |
5,819 |
437 |
6,256 |
Profit for the period |
– |
– |
– |
– |
253 |
253 |
21 |
274 |
Other comprehensive income |
– |
– |
(1) |
(72) |
(46) |
(119) |
(6) |
(125) |
Comprehensive income for the period |
– |
– |
(1) |
(72) |
207 |
134 |
15 |
149 |
Dividend |
– |
– |
– |
– |
– |
– |
(2) |
(2) |
Equity-settled transactions |
– |
– |
– |
– |
8 |
8 |
– |
8 |
Issue of common shares |
1 |
(1) |
– |
– |
– |
– |
– |
– |
Balance at March 31, 2018 |
506 |
768 |
14 |
(621) |
5,294 |
5,961 |
450 |
6,411 |
|
|
|
|
|
|
|
|
|
Balance at December 31, 2018 |
512 |
958 |
– |
(608) |
10,972 |
11,834 |
204 |
12,038 |
Profit for the period |
– |
– |
– |
– |
65 |
65 |
9 |
74 |
Other comprehensive income |
– |
– |
– |
153 |
(93) |
60 |
3 |
63 |
Comprehensive income for the period |
– |
– |
– |
153 |
(28) |
125 |
12 |
137 |
Dividend |
– |
– |
– |
– |
(1,026) |
(1,026) |
(2) |
(1,028) |
Share repurchase |
– |
– |
– |
– |
(327) |
(327) |
– |
(327) |
Capital repayment and share consolidation |
(399) |
(958) |
– |
– |
(643) |
(2,000) |
– |
(2,000) |
Equity-settled transactions |
– |
– |
– |
– |
5 |
5 |
– |
5 |
Issue of common shares |
1 |
– |
– |
– |
(1) |
– |
– |
– |
Balance at March 31, 2019 |
114 |
– |
– |
(455) |
8,952 |
8,611 |
214 |
8,825 |
Shareholders’ equity
Shareholders’ equity decreased from €11.8 billion at year-end 2018 to €8.6 billion at the end of March 31, 2019, mainly due to the net effect of:
- Profit for the period of €65 million
- Currency effects of €153 million positive (including taxes)
- Actuarial losses of €93 million (including taxes)
- Capital repayment and share consolidation of €2.0 billion
- Special cash dividend of €1.0 billion
- Share repurchase of €0.3 billion
Dividend
Our dividend policy is to pay a stable to rising dividend. A final 2018 dividend of €1.43 per consolidated share is proposed for approval at the AGM, which would equal a total 2018 dividend of €1.80 (2017: €2.50, including €0.85 related to the Specialty Chemicals business) per share.
In line with our announcement on April 19, 2017, we intend to return the vast majority of the net proceeds from the separation of the Specialty Chemicals business to our shareholders:
- The Extraordinary General Meeting of November 13, 2018, approved to return an amount of €2.0 billion to shareholders by means of a capital repayment and share consolidation which was executed in January 2019. A share consolidation ratio of 9:8 was applied.
- We distributed €1.0 billion by means of a special cash dividend of €4.50 per common share (post consolidation) on February 25, 2019.
- A share buyback program to repurchase common shares up to the value of €2.5 billion has started and is due to be completed at the end of 2019. €0.3 billion was executed in the first quarter of 2019. We intend to cancel these shares after repurchase.
Please refer to the Financial calendar for dividend payment dates.